“Global Diagnostic Imaging market set to grow to $32bn by 2024” says Visiongain report
20 September 2019
Visiongain has launched a new pharma report Global Diagnostic Imaging Market Forecast: MRI Systems, Ultrasound Imaging Systems, CT Scanners, Nuclear Imaging, X-Ray Imaging, Mammography, Cardiology, Gynecology/Obs, Orthopaedics & Musculoskeletal, Radiology, Neurology & Spine, General Imaging, Hospitals, Diagnostic Imaging Centers.
Diagnostic imaging is an integral part of treatment decisions and also plays a role in therapy planning, therapy monitoring and follow-up.
The lead analyst of the report commented "Diagnostic imaging technology such as MRI and CT scans has become more precise and accessible, due to which radiology has increasingly become a key foundation of modern medicine. Currently, many of the diagnostic imaging devices are powered by artificial intelligence and machine learning. This would significantly improve diagnostic quality, efficiency, and treatment patterns.
The high cost associated with the clinical trials and development of diagnostic imaging devices coupled with the inefficient infrastructure is likely to impede the growth of the diagnostic imaging market."
Leading companies featured in the report include Canon, Inc., Carestream Health, Inc., Esaote SPA, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi, Ltd., Koninklijke Philips N.V. (Royal Philips), Samsung Electronics Co., Ltd., Shimadzu Corporation, Siemens Healthineers AG and other companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.
About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Recent News
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
20 March 2023
Read
Visiongain Publishes eClinical Solutions Market Report 2023-2033
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
17 March 2023
Read
Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
15 March 2023
Read
Visiongain Publishes Regenerative Medicine Market Report 2023-2033
The global Regenerative Medicine market was valued at US$ 50.37 billion in 2022 and is projected to grow at a CAGR of 18.40% during the forecast period 2023-2033.